Zili Chen

Synthesis and biological evaluation of RGD-conjugated MEK1/2 kinase inhibitors for integrin-targeted cancer therapy.

Chao Wang, P. Xu, Zhenjun Yang, 2013, Molecules.

Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy

Chao Wang, P. Xu, Zhenjun Yang, 2013, Molecules.

Antinociceptive Pharmacology of N-(4-Chlorobenzyl)-N′-(4-hydroxy-3-iodo-5-methoxybenzyl) Thiourea, a High-Affinity Competitive Antagonist of the Transient Receptor Potential Vanilloid 1 Receptor

P. Blumberg, Zili Chen, A. Kozikowski, 2007, Journal of Pharmacology and Experimental Therapeutics.

RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy.

Zhenjun Yang, Jianjun Hou, Zili Chen, 2016, International journal of pharmaceutics.

AM1241 alleviates myocardial ischemia-reperfusion injury in rats by enhancing Pink1/Parkin-mediated autophagy.

Zili Chen, Lu-yuan Tao, Xingjian Gu, 2021, Life sciences.

Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population.

P. Blumberg, Zili Chen, A. Kozikowski, 2004, Molecular pharmacology.

Identification of catalytically active domain epitopes in neuraminidase protein of H9N2 subtype of avian influenza virus

Zili Chen, G. Yin, Xiangyu Huang, 2023, Avian pathology : journal of the W.V.P.A.